Evidence map›Paper›PMID 42705671›Full record

GuidelineEndocrinology and metabolism (Seoul, Korea)2026

Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers, Part II: Follow-up Surveillance after Initial Treatment 2026.

Eun Kyung Lee, Seung Heon Kang, Bon Seok Koo, Mijin Kim, Min Joo Kim, Bo Hyun Kim, Ji Won Kim, Dong Gyu Na, Sohyun Park, Ji-In Bang and 23 more

Abstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Endocrinology and metabolism (Seoul, Korea), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Eun Kyung LeeDepartment of Internal Medicine, National Cancer Center, Goyang, Korea.
Seung Heon KangDepartment of Otolaryngology-Head and Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Bon Seok KooDepartment of Otolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Korea.
Mijin KimDepartment of Internal Medicine, Pusan National University Hospital, Busan, Korea.
Min Joo KimDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Bo Hyun KimDepartment of Internal Medicine, Pusan National University Hospital, Busan, Korea.
Ji Won KimDepartment of Otolaryngology-Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Korea.
Dong Gyu NaDepartment of Radiology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.
Sohyun ParkDepartment of Nuclear Medicine, National Cancer Center, Goyang, Korea.
Ji-In BangDepartment of Nuclear Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
Kyorim BackDepartment of Surgery, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea.
Youngduk SeoDepartment of Nuclear Medicine, Chungnam National University Sejong Hospital, Sejong, Korea.
Young-Ik SonDepartment of Otolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Young Shin SongDepartment of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
Dong Yeob ShinDepartment of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Jong-Hyuk AhnDepartment of Surgery, Chung-Ang University Hospital, Seoul, Korea.
Hwa Young AhnDepartment of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea.
So Won OhDepartment of Nuclear Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
Ho-Ryun WonDepartment of Otolaryngology-Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Korea.
Won Sang YooDepartment of Internal Medicine, Dankook University Hospital, Cheonan, Korea.
Min Kyoung LeeDepartment of Radiology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Sang-Woo LeeDepartment of Nuclear Medicine, Kyungpook National University Chilgok Hospital, Daegu, Korea.
Jeongmin LeeDepartment of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Ji Ye LeeDepartment of Radiology, Seoul National University Hospital, Seoul, Korea.
Dong-Jun LimDepartment of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Ki-Wook ChungDepartment of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Ari ChongDepartment of Nuclear Medicine, Chosun University Hospital, Gwangju, Korea.
Jin Hyang JungDepartment of Surgery, Kyungpook National University Chilgok Hospital, Daegu, Korea.
Sun Wook ChoDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Yoon Young ChoDepartment of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
Chae Moon HongDepartment of Nuclear Medicine, Kyungpook National University Hospital, Daegu, Korea.
Young Joo ParkDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Korea. yjparkmd@snu.ac.kr.
Korean Thyroid Association Guideline Committee on the Management of Thyroid Nodule and Cancer

Funding

Korean Thyroid AssociationMinistry of Health and WelfareNational Cancer Care Guideline Research Grant 2112570Patient-Centered Clinical Research Coordinating Center RS-2024-00398702
6 · The paper itself

Abstract

In patients with differentiated thyroid cancer, initial recurrence-risk stratification based on clinical, histopathological, and perioperative findings remains central to management during the first 1-2 years after initial treatment. Ongoing risk stratification (ORS) complements this initial assessment by continuously integrating longitudinal clinical data and treatment response, thereby refining long-term prognostic assessment and supporting individualized risk-adapted management. Building on the 2024 Korean Thyroid Association (KTA) guidelines, the 2026 KTA guideline incorporates new evidence from large Korean multicenter cohorts and comprehensive systematic reviews. The updated recommendations reinforce the continued application of ORS and provide more specific guidance on risk-adapted thyroid-stimulating hormone (TSH) targets, surveillance strategies for recurrence detection, and long-term follow-up tailored to individual recurrence risk and treatment response. Consistent with the evolving paradigm toward risk-adapted and individualized management, this revision updates recommendations regarding target serum TSH levels, serum thyroglobulin thresholds for response assessment and long-term surveillance, and follow-up intervals based on both initial-risk category and the ORS response category. These evidence-based recommendations aim to minimize unnecessary treatment and excessive surveillance in the majority of patients who have an excellent prognosis after initial therapy while ensuring individualized long-term management for patients who require closer surveillance or additional therapeutic intervention.

Indexed as

Neoplasm Recurrence, LocalPractice Guidelines as TopicThyroid NeoplasmsFollow-Up StudiesHumansPrognosisRepublic of KoreaRisk AssessmentSocieties, MedicalThyrotropinThyrotropinDifferentiated thyroid cancerGuidelineOngoing risk stratificationSurveillanceThyroid-stimulating hormone target

Identifiers

PMID42705671
PMCPMC13555224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.